Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
Clearing of the dormant liver stage (the hypnozoite) of P. vivax malaria is important to prevent the relapse of infection. In this randomized clinical trial, a single dose of tafenoquine is shown to have significant activity against the hypnozoite form of P. vivax .
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2019-01, Vol.380 (3), p.215-228 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Clearing of the dormant liver stage (the hypnozoite) of
P. vivax
malaria is important to prevent the relapse of infection. In this randomized clinical trial, a single dose of tafenoquine is shown to have significant activity against the hypnozoite form of
P. vivax
. |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMoa1710775 |